Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and...
markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(25)
•••
24minus7
X
View Profile
View Bullboard History
Post by
24minus7
on Jul 06, 2024 12:02pm
Something personal (please don't share)
AbbVie's due diligence at Sirona Biochem: Deeper than my ex's fake apologies.
(25)
•••
24minus7
X
View Profile
View Bullboard History
Post by
24minus7
on Jul 06, 2024 11:56am
Dr. Verrico nominated for Paris 2024
Oh, Dr. Verrico, the tireless guardian of this never-ending saga. What a noble pursuit, toiling away for years to keep this riveting tale alive. Surely, there must be some deeply personal and profound
...more
(25)
•••
24minus7
X
View Profile
View Bullboard History
Post by
24minus7
on Jul 06, 2024 11:22am
GDG for gold
Geraldine Deliencourt-Godefroy's eyes sparkled with enthusiasm, reflecting the same youthful vibrancy she promised the anti-aging compound could deliver. It was clear she wasn't just
...more
(25)
•••
24minus7
X
View Profile
View Bullboard History
Post by
24minus7
on Jul 06, 2024 10:17am
Somebody once said...
...we @Sirona don't just bottle youth, we uncork success (and maybe pop a few champagne bottles along the way). ( ^-^)∠.:*:'°
(25)
•••
24minus7
X
View Profile
View Bullboard History
Post by
24minus7
on Jul 06, 2024 6:44am
Are you a Dancing Investor? \(_ _)
Sirona Biochem: We're not just making wrinkles disappear, we're making investors smile (and maybe dance a little jig).
(25)
•••
24minus7
X
View Profile
View Bullboard History
Post by
24minus7
on Jul 06, 2024 5:57am
(*^-゜)vThanks!
Dr. Verrico, demonstrating his astute judgment, has reviewed and approved the contract, ensuring the survival of our Sirona at any cost.
(25)
•••
24minus7
X
View Profile
View Bullboard History
Post by
24minus7
on Jul 06, 2024 2:38am
2025 is in the air\(^_^)/
The mid-2025 timeframe presents exciting possibilities for AbbVie's involvement with this asset, potentially through royalties or a complete takeover.
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Jul 05, 2024 3:27pm
RE:RE:RE:Nice to see someone buying for a change
We have all tried bid support at some point over the years, never lasts long, look where we are. Too many share outstanding and too little news. Or Howie just dilutes into any price action.
...more
(25)
•••
24minus7
X
View Profile
View Bullboard History
Post by
24minus7
on Jul 05, 2024 1:05pm
Launch Vibes
AbbVie's substantial 4-year investment in SkinMedica demonstrates strong confidence in TFC-1067's potential. This suggests a well-defined strategy for the product's success within the
...more
(65)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Jul 05, 2024 12:52pm
RE:RE:Nice to see someone buying for a change
Why don't you make it fly? Hit the buy button and create some action instead of the depressive complaints!
(14)
•••
moneycollector
X
View Profile
View Bullboard History
Comment by
moneycollector
on Jul 05, 2024 11:29am
RE:Nice to see someone buying for a change
Back @ 4.5 cents... shi.t never flies, it only falls!
(1806)
•••
tylerreddick
X
View Profile
View Bullboard History
Post by
tylerreddick
on Jul 04, 2024 8:14pm
Nice to see someone buying for a change
And I guess it just shows what might happen if they can just get something going. Either AbbVie or that partner for Sirona Labs, I don't care which comes first.
(37)
•••
Turtle4
X
View Profile
View Bullboard History
Comment by
Turtle4
on Jul 04, 2024 3:47am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New all time low at 0.04 cad?
I think the PRC figures would be quite realistic if the license went to a global cosmetics company. Skinmedica is only really represented in North America. The large skin lightening market will
...more
(2233)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jul 03, 2024 8:31pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New all time low at 0.04 cad?
I don't know what PRC got for that pump but they should have got life.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >